Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aging and heparin-related bleeding

N R Campbell1, R D Hull, R Brant

  • 1Department of Medicine, Faculty of Medicine, University of Calgary, Alberta.

Archives of Internal Medicine
|April 22, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomized controlled trial to prevent obesity among Latino paediatric patients.

Pediatric obesity·2018
Same author

Authors' reply re: Perinatal and maternal morbidity and mortality among term singletons following midcavity operative vaginal delivery versus caesarean delivery.

BJOG : an international journal of obstetrics and gynaecology·2017
Same author

Perinatal and maternal morbidity and mortality among term singletons following midcavity operative vaginal delivery versus caesarean delivery.

BJOG : an international journal of obstetrics and gynaecology·2017
Same author

Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Role of Organics in Regulating ClNO₂ Production at the Air-Sea Interface.

The journal of physical chemistry. A·2015
Same author

Buprenorphine: a new player in neonatal withdrawal syndrome.

The West Virginia medical journal·2015
Same journal

Elevated CK-MB With Normal Total Creatine Kinase Levels in Patients Undergoing Maintenance Hemodialysis-Reply.

Archives of internal medicine·2017
Same journal

Occult Carbon Monoxide Poisoning-Reply.

Archives of internal medicine·2017
Same journal

Acquired Immune Deficiency Syndrome-Reply.

Archives of internal medicine·2017
Same journal

Heparin Side Effects-Reply.

Archives of internal medicine·2017
Same journal

Humanizing primary care medicine begins with stress.

Archives of internal medicine·2017
Same journal

Legend omitted and number misrepresented.

Archives of internal medicine·2013
See all related articles

Aging increases bleeding risk during heparin therapy, independent of other factors. This may be due to age-related changes affecting how the body processes heparin, leading to higher drug levels and bleeding complications in older patients.

Area of Science:

  • Pharmacology
  • Geriatrics
  • Thrombosis

Background:

  • Elderly patients exhibit a higher risk of bleeding during heparin therapy.
  • The cause of this increased bleeding risk in older adults remains unclear, with potential links to aging itself or coexisting risk factors.

Purpose of the Study:

  • To determine if the increased bleeding risk in elderly patients receiving heparin is due to aging itself or other concurrent risk factors.
  • To investigate the relationship between aging, heparin levels, and bleeding complications.

Main Methods:

  • A double-blind, randomized, prospective study involving 199 patients with proximal deep vein thrombosis treated with a standard intravenous heparin protocol.
  • Monitoring of bleeding complications, activated partial thromboplastin times (aPTT), and heparin levels at specific time points during heparin administration.

Related Experiment Videos

  • Assessment of heparin doses and levels after achieving stable therapeutic infusion rates.

    • Main Results:

    • An increased incidence of total and major bleeding complications was observed with advancing age (P < .05), not explained by known bleeding risk factors.
    • Aging correlated with elevated heparin levels (r = .239, P = .003) and a trend toward higher aPTT (r = .134, P = .07) after standard heparin doses.
    • Older patients required lower heparin doses to achieve therapeutic aPTT levels (r = .267, P = .003).

    Conclusions:

    • Aging is identified as an independent risk factor for heparin-related bleeding.
    • Age-related alterations in heparin pharmacokinetics may explain the increased bleeding risk in the elderly.
    • These findings suggest a need for careful heparin dose adjustment in elderly patients to mitigate bleeding risks.